SRZN (STOCKS)
Surrozen, Inc. Common
$23.140000
-0.250000 (-1.07%)
Prev close: $23.390000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Craig C. Parker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $268.55M
- Employees
- 41
- P/E (TTM)
- -0.56
- P/B (TTM)
- -0.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $7.49M |
| Benefits Costs and Expenses | $350.06M |
| Costs And Expenses | $350.06M |
| Operating Expenses | $50.49M |
| Depreciation and Amortization | $308.00K |
| Research and Development | $32.14M |
| Other Operating Expenses | $18.25M |
| Operating Income/Loss | -$43.00M |
| Income/Loss From Continuing Operations After Tax | -$342.56M |
| Income/Loss From Continuing Operations Before Tax | -$342.56M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$342.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$342.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$360.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$17.94M |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$41.34 |
| Diluted Earnings Per Share | -$41.34 |
| Basic Average Shares | 28,608 |
| Diluted Average Shares | 28,608 |
| Assets | $120.71M |
| Current Assets | $113.95M |
| Noncurrent Assets | $6.76M |
| Fixed Assets | $488.00K |
| Other Non-current Assets | $6.27M |
| Liabilities | $398.86M |
| Current Liabilities | $9.57M |
| Accounts Payable | $889.00K |
| Other Current Liabilities | $8.68M |
| Noncurrent Liabilities | $389.29M |
| Equity | -$278.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$278.15M |
| Liabilities And Equity | $120.71M |
| Net Cash Flow From Operating Activities | -$33.46M |
| Net Cash Flow From Operating Activities, Continuing | -$33.46M |
| Net Cash Flow From Investing Activities | -$221.00K |
| Net Cash Flow From Investing Activities, Continuing | -$221.00K |
| Net Cash Flow From Financing Activities | $38.95M |
| Net Cash Flow From Financing Activities, Continuing | $38.95M |
| Net Cash Flow | $5.27M |
| Net Cash Flow, Continuing | $5.27M |
| Comprehensive Income/Loss | -$342.56M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$342.56M |
| Other Comprehensive Income/Loss | $0.00 |